porphobilinogen has been researched along with Neoplasms in 12 studies
Neoplasms: New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The excretion of delta-aminolevulinic acid and porphobilinogen in the urine of 31 patients with multiple sclerosis did not differ significantly from that of 51 hospitalized control patients or eight patients with poliomyelitis." | 7.64 | PORPHOBILINOGEN AND DELTA-AMINOLEVULINIC ACID EXCRETION IN MULTIPLE SCLEROSIS. ( MARKLE, V; PAZDER, LH; TAYLOR, JD, 1965) |
| "The excretion of delta-aminolevulinic acid and porphobilinogen in the urine of 31 patients with multiple sclerosis did not differ significantly from that of 51 hospitalized control patients or eight patients with poliomyelitis." | 3.64 | PORPHOBILINOGEN AND DELTA-AMINOLEVULINIC ACID EXCRETION IN MULTIPLE SCLEROSIS. ( MARKLE, V; PAZDER, LH; TAYLOR, JD, 1965) |
| "Here, an intelligent anticancer nanoplatform based on an Aza-boron-dipyrromethene dye (denoted as Aza-BDY) is elaborately established for ferroptosis augmented SDT through cysteine (Cys) starvation." | 1.72 | Self-Assembled Aza-Boron-Dipyrromethene for Ferroptosis-Boosted Sonodynamic Therapy. ( Chen, H; Chen, Y; Li, X; Liang, L; Wang, D; Xiang, H; You, C; Zhao, Y, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (25.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (25.00) | 24.3611 |
| 2020's | 6 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lin, X | 1 |
| Chen, F | 1 |
| Yu, X | 1 |
| Wang, H | 1 |
| Qiu, H | 1 |
| Li, Y | 1 |
| Yin, S | 1 |
| Stang, PJ | 1 |
| Xing, X | 1 |
| Yang, K | 1 |
| Li, B | 1 |
| Tan, S | 1 |
| Yi, J | 1 |
| Li, X | 2 |
| Pang, E | 1 |
| Wang, B | 1 |
| Song, X | 1 |
| Lan, M | 1 |
| You, C | 1 |
| Wang, D | 1 |
| Chen, H | 1 |
| Liang, L | 1 |
| Chen, Y | 1 |
| Zhao, Y | 1 |
| Xiang, H | 1 |
| Yang, DC | 1 |
| Wen, LF | 1 |
| Du, L | 1 |
| Luo, CM | 1 |
| Lu, ZY | 1 |
| Liu, JY | 1 |
| Lin, Z | 1 |
| Lin, W | 1 |
| Colombani-Garay, D | 1 |
| Huang, L | 1 |
| Duan, C | 1 |
| Han, G | 1 |
| Curtin, N | 1 |
| Wu, D | 1 |
| Cahill, R | 1 |
| Sarkar, A | 1 |
| Aonghusa, PM | 1 |
| Zhuk, S | 1 |
| Barberio, M | 1 |
| Al-Taher, M | 1 |
| Marescaux, J | 1 |
| Diana, M | 1 |
| O'Shea, DF | 1 |
| Sun, W | 1 |
| Zhao, X | 1 |
| Fan, J | 1 |
| Du, J | 1 |
| Peng, X | 1 |
| Myochin, T | 1 |
| Hanaoka, K | 1 |
| Komatsu, T | 1 |
| Terai, T | 1 |
| Nagano, T | 1 |
| Rai, A | 1 |
| Surolia, A | 1 |
| Panda, D | 1 |
| SCHLENKER, FS | 1 |
| TAYLOR, NA | 1 |
| KIEHN, BP | 1 |
| TAYLOR, JD | 1 |
| PAZDER, LH | 1 |
| MARKLE, V | 1 |
| Ramsdell, CM | 1 |
| Kelley, WN | 1 |
2 reviews available for porphobilinogen and Neoplasms
| Article | Year |
|---|---|
Tailoring nanoparticles based on boron dipyrromethene for cancer imaging and therapy.
Topics: Animals; Boron; Diagnostic Imaging; Drug Compounding; Humans; Nanoparticles; Neoplasms; Porphobilino | 2020 |
Boron Dipyrromethene Nano-Photosensitizers for Anticancer Phototherapies.
Topics: Animals; Antineoplastic Agents; Boron; Humans; Neoplasms; Photosensitizing Agents; Phototherapy; Por | 2019 |
10 other studies available for porphobilinogen and Neoplasms
| Article | Year |
|---|---|
Phenylthiol-BODIPY-based supramolecular metallacycles for synergistic tumor chemo-photodynamic therapy.
Topics: Boron Compounds; Cell Line, Tumor; Coordination Complexes; Drug Synergism; Humans; Neoplasms; Photoc | 2022 |
Boron Dipyrromethene-Based Phototheranostics for Near Infrared Fluorescent and Photoacoustic Imaging-Guided Synchronous Photodynamic and Photothermal Therapy of Cancer.
Topics: Boron; Boron Compounds; HeLa Cells; Humans; Nanoparticles; Neoplasms; Photoacoustic Techniques; Phot | 2022 |
Self-Assembled Aza-Boron-Dipyrromethene for Ferroptosis-Boosted Sonodynamic Therapy.
Topics: Boron; Cell Line, Tumor; Cysteine; Ferroptosis; Humans; Nanoparticles; Neoplasms; Porphobilinogen; R | 2022 |
A Hypoxia-Activated Prodrug Conjugated with a BODIPY-Based Photothermal Agent for Imaging-Guided Chemo-Photothermal Combination Therapy.
Topics: Azo Compounds; Boron; Boron Compounds; Camptothecin; Cell Line, Tumor; Humans; Hyperthermia, Induced | 2022 |
Dual Color Imaging from a Single BF
Topics: Animals; Endoscopy; Female; Fluorescent Dyes; HeLa Cells; Humans; Intraoperative Care; Intravital Mi | 2021 |
Design strategy for a near-infrared fluorescence probe for matrix metalloproteinase utilizing highly cell permeable boron dipyrromethene.
Topics: Animals; Boron Compounds; Cell Line, Tumor; Cell Membrane Permeability; Cell Survival; Fluorescence; | 2012 |
An antitubulin agent BCFMT inhibits proliferation of cancer cells and induces cell death by inhibiting microtubule dynamics.
Topics: Animals; Calcium-Binding Proteins; Cell Cycle; Cell Cycle Proteins; Cell Death; Cell Line, Tumor; Ce | 2012 |
THE CHROMATOGRAPHIC SEPARATION, DETERMINATION, AND DAILY EXCRETION OF URINARY PORPHOBILINOGEN, AMINO ACETONE, AND DELTA-AMINOLEVULINIC ACID.
Topics: Acetone; Aminolevulinic Acid; Anemia; Anemia, Sickle Cell; Chromatography; Fluids and Secretions; Ho | 1964 |
PORPHOBILINOGEN AND DELTA-AMINOLEVULINIC ACID EXCRETION IN MULTIPLE SCLEROSIS.
Topics: Amino Acids; Aminolevulinic Acid; Demyelinating Diseases; Diagnosis, Differential; Fluids and Secret | 1965 |
The clinical significance of hypouricemia.
Topics: Allopurinol; Amino Acids; Aspirin; Autoanalysis; Creatinine; Glycosuria; Humans; Kidney Diseases; Ne | 1974 |